Fetus treated with risdiplam for rare genetic disorder, a medical first
HQ Team February 27, 2025: A study published in The New England Journal of Medicine (NEJM) reveals that administration of the oral drug.
Drugs
Health
Drugs
Medical
Pharma
Eli Lilly to set up four manufacturing facilities in US for $27 billion
Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according.
Drugs
Health
Medical
WHO Foundation to crowdsource funds for global health programmes
The World Health Organization is crowdsourcing to fund its health programs by urging individuals globally to donate to the ‘1 Dollar 1 World.
Drugs
Health
Pharma
AstraZeneca says trial breast cancer drug improves survival rates
AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the.
Drugs
Health
Medical
Unknown illness sweeps across Congo’s northwest, 53 people die
A mystery illness sweeping over Congo has killed 53 people and infected 400 more, with an initial probe tracking the outbreak to three.
Drugs
Health
Pharma
Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats
Eli Lilly and Company cut the prices of its weight-loss drug Zepbound, available in single-dose vials, in a bid to end compounding companies from.
Drugs
Health
Medical
Regeneron’s trial therapy improves hearing in children with gene mutations
Regeneron Pharmaceuticals, Inc.’s investigational gene therapy improved hearing in 10 out of 11 children born with hearing loss because of gene mutation, according.
Drugs
Health
Pharma
Breast cancer death rates globally to rise 68% by 2050: WHO arm IARC warns
Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.
Drugs
Health
Medical
US regulator clears Mirum’s oral drug for reducing cholesterol deposits
Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.
Drugs
Health
Artificial sweeteners spike insulin levels, increasing risk of heart diseases
HQ Team February 21, 2025: Artificial sweeteners, long used as low-calorie alternatives to sugar, are known to cause a number of health conditions,.